- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Influenza
- Meeting Date: March 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 669KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 101KB)
Diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and haemophilus influenzae type b conjugate vaccine – March 2022
Diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and haemophilus influenzae type b conjugate vaccine (DTPa-HB-IPV-Hib): 0.5 mL pre-filled syringe; Vaxelis™
Last updated
8 July 2025